{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:38:51Z","timestamp":1794843531676,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["209274\/Z\/17\/Z"],"award-info":[{"award-number":["209274\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jvacx.2024.100438","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T02:50:32Z","timestamp":1705114232000},"page":"100438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["BpOmpW antigen administered with CAF01 adjuvant stimulates comparable T cell responses to Sigma adjuvant system"],"prefix":"10.1016","volume":"17","author":[{"given":"Julen","family":"Tom\u00e1s-Cort\u00e1zar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2382-8639","authenticated-orcid":false,"given":"Dennis","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6389-2542","authenticated-orcid":false,"given":"Siobh\u00e1n","family":"McClean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jvacx.2024.100438_b0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","article-title":"Melioidosis: epidemiology, pathophysiology, and management","volume":"18","author":"Cheng","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jvacx.2024.100438_b0010","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.1038\/nrdp.2017.107","volume":"4","author":"Wiersinga","year":"2018","journal-title":"Melioidosis Nat Rev Dis Primers"},{"key":"10.1016\/j.jvacx.2024.100438_b0015","doi-asserted-by":"crossref","first-page":"15008","DOI":"10.1038\/nmicrobiol.2015.8","article-title":"Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis","volume":"1","author":"Limmathurotsakul","year":"2016","journal-title":"Nat Microbiol"},{"issue":"7","key":"10.1016\/j.jvacx.2024.100438_b0020","doi-asserted-by":"crossref","first-page":"e0270997","DOI":"10.1371\/journal.pone.0270997","article-title":"Low risk of acquiring melioidosis from the environment in the continental United States","volume":"17","author":"Hall","year":"2022","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100438_b0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4269\/ajtmh.2010.10-0038","article-title":"Increasing incidence of human melioidosis in Northeast Thailand","volume":"82","author":"Limmathurotsakul","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jvacx.2024.100438_b0030","doi-asserted-by":"crossref","unstructured":"N.H. Cho J.E. Shaw S. Karuranga Y. Huang J.D. da Rocha Fernandes A.W. Ohlrogge B. Malanda IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045 Diabetes Res Clin Pract 138 2018 271 281.","DOI":"10.1016\/j.diabres.2018.02.023"},{"key":"#cr-split#-10.1016\/j.jvacx.2024.100438_b0035.1","doi-asserted-by":"crossref","unstructured":"P. Saeedi I. Petersohn P. Salpea B. Malanda S. Karuranga N. Unwin S. Colagiuri L. Guariguata A.A. Motala K. Ogurtsova J.E. Shaw D. Bright R. Williams I.D.F.D.A. Committee Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas 9","DOI":"10.1016\/j.diabres.2019.107843"},{"key":"#cr-split#-10.1016\/j.jvacx.2024.100438_b0035.2","doi-asserted-by":"crossref","unstructured":"(th) edition Diabetes Res Clin Pract 157 2019 107843.","DOI":"10.1016\/j.diabres.2019.107843"},{"issue":"23","key":"10.1016\/j.jvacx.2024.100438_b0040","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.vaccine.2016.03.088","article-title":"Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis","volume":"34","author":"Casey","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100438_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767359","article-title":"BpOmpW antigen stimulates the necessary protective T-cell responses against melioidosis","volume":"12","author":"Tomas-Cortazar","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.jvacx.2024.100438_b0050","doi-asserted-by":"crossref","first-page":"e0004152","DOI":"10.1371\/journal.pntd.0004152","article-title":"T-cell responses are associated with survival in acute melioidosis patients","volume":"9","author":"Jenjaroen","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100438_b0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3201\/eid2603.190206","article-title":"Human immune responses to melioidosis and cross-reactivity to low-virulence burkholderia species, Thailand(1)","volume":"26","author":"Rongkard","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.jvacx.2024.100438_b0060","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100438_b0065","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciy1087","article-title":"Controlled human malaria infection of healthy adults with lifelong malaria exposure to assess safety, immunogenicity, and efficacy of the asexual blood stage malaria vaccine candidate GMZ2","volume":"69","author":"Dejon-Agobe","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100438_b0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.smim.2018.10.003","article-title":"Immunocorrelates of CAF family adjuvants","volume":"39","author":"Pedersen","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jvacx.2024.100438_b0075","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3389\/fimmu.2020.00803","volume":"11","author":"Thakur","year":"2020","journal-title":"Front Immunol"},{"issue":"52","key":"10.1016\/j.jvacx.2024.100438_b0080","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human","volume":"32","author":"van Dissel","year":"2014","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.jvacx.2024.100438_b0085","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.vaccine.2017.02.020","article-title":"The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge","volume":"35","author":"Pal","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100438_b0090","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2017.00569","article-title":"Simultaneous subcutaneous and intranasal administration of a CAF01-adjuvanted chlamydia vaccine elicits elevated IgA and protective Th1\/Th17 responses in the genital tract","volume":"8","author":"Wern","year":"2017","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jvacx.2024.100438_b0095","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/eji.201848037","article-title":"Diabetes alters immune response patterns to acute melioidosis in humans","volume":"49","author":"Kronsteiner","year":"2019","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jvacx.2024.100438_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.965518","article-title":"Evaluation of two different vaccine platforms for immunization against melioidosis and glanders","volume":"13","author":"Biryukov","year":"2022","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100438_b0105","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00724-17","article-title":"Development of subunit vaccines that provide high-level protection and sterilizing immunity against acute inhalational melioidosis","volume":"86","author":"Burtnick","year":"2018","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100438_b0110","doi-asserted-by":"crossref","first-page":"e0122721","DOI":"10.1128\/mBio.01227-21","article-title":"Multicomponent gold-linked glycoconjugate vaccine elicits antigen-specific humoral and mixed T(H)1-T(H)17 immunity, correlated with increased protection against burkholderia pseudomallei","volume":"12","author":"Tapia","year":"2021","journal-title":"MBio"},{"issue":"46","key":"10.1016\/j.jvacx.2024.100438_b0115","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1016\/j.vaccine.2011.08.058","article-title":"A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection","volume":"29","author":"Nieves","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100438_b0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41541-021-00281-z","article-title":"Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine","volume":"6","author":"Baker","year":"2021","journal-title":"npj Vaccines"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100438_b0125","article-title":"Deletion of two genes in burkholderia pseudomallei MSHR668 That target essential amino acids protect acutely infected BALB\/c mice and promote long term survival","volume":"7","author":"Amemiya","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100438_b0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41541-021-00333-4","article-title":"Antigen-specific antibody and polyfunctional T cells generated by respiratory immunization with protective Burkholderia DeltatonB Deltahcp1 live attenuated vaccines","volume":"6","author":"Khakhum","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.jvacx.2024.100438_b0135","doi-asserted-by":"crossref","first-page":"19570","DOI":"10.1038\/srep19570","article-title":"Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens","volume":"6","author":"Knudsen","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100438_b0140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.vaccine.2019.10.047","article-title":"Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal priming","volume":"38","author":"McEntee","year":"2020","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jvacx.2024.100438_b0145","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstrom","year":"2009","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jvacx.2024.100438_b0150","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1128\/IAI.00550-12","article-title":"Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset","volume":"80","author":"Lindenstrom","year":"2012","journal-title":"Infect Immun"},{"issue":"20","key":"10.1016\/j.jvacx.2024.100438_b0155","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers","volume":"28","author":"van Dissel","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100438_b0160","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/498983","article-title":"Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection","volume":"193","author":"Haque","year":"2006","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.jvacx.2024.100438_b0165","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1073\/pnas.1220601110","article-title":"Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs","volume":"110","author":"Tatituri","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.jvacx.2024.100438_b0170","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2811","article-title":"Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity","volume":"18","author":"Zeissig","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jvacx.2024.100438_b0175","doi-asserted-by":"crossref","first-page":"39097","DOI":"10.1038\/srep39097","article-title":"Comparative systems analyses reveal molecular signatures of clinically tested vaccine adjuvants","volume":"6","author":"Olafsdottir","year":"2016","journal-title":"Sci Rep"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:11:41Z","timestamp":1762913501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136224000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":36,"alternative-id":["S2590136224000111"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100438","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BpOmpW antigen administered with CAF01 adjuvant stimulates comparable T cell responses to Sigma adjuvant system","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100438"}}